LU92549I2 -
An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;
- Google Patents
An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Intellectual Property LtdfiledCriticalGlaxosmithkline Intellectual Property Ltd
Publication of LU92549I2publicationCriticalpatent/LU92549I2/en
LU92549C2001-12-212014-09-17
An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;
LU92549I2
(en)
An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;
An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;